{"id":"https://openalex.org/W2900959173","doi":"https://doi.org/10.1097/ede.0000000000000944","title":"The Case\u2013Crossover Design for Drug\u2013Drug Interactions","display_name":"The Case\u2013Crossover Design for Drug\u2013Drug Interactions","publication_year":2018,"publication_date":"2018-11-16","ids":{"openalex":"https://openalex.org/W2900959173","doi":"https://doi.org/10.1097/ede.0000000000000944","mag":"2900959173","pmid":"https://pubmed.ncbi.nlm.nih.gov/30433922"},"language":"en","primary_location":{"id":"doi:10.1097/ede.0000000000000944","doi":"https://doi.org/10.1097/ede.0000000000000944","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ede.0000000000000944","pdf_url":null,"source":{"id":"https://openalex.org/S15470582","display_name":"Epidemiology","issn_l":"1044-3983","issn":["1044-3983","1531-5487"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epidemiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083832003","display_name":"Katsiaryna Bykov","orcid":"https://orcid.org/0000-0003-3336-5412","observed_orcids":["https://orcid.org/0000-0003-3336-5412"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katsiaryna Bykov","raw_affiliation_strings":["Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","Submitted April 6, 2018","Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","accepted November 12, 2018"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Submitted April 6, 2018","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","institution_ids":[]},{"raw_affiliation_string":"accepted November 12, 2018","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074938224","display_name":"Murray A. Mittleman","orcid":"https://orcid.org/0000-0001-9788-7274","observed_orcids":["https://orcid.org/0000-0001-9788-7274"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Murray A. Mittleman","raw_affiliation_strings":["Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","Submitted April 6, 2018","Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","accepted November 12, 2018"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Submitted April 6, 2018","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","institution_ids":[]},{"raw_affiliation_string":"accepted November 12, 2018","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037322697","display_name":"Robert J. Glynn","orcid":"https://orcid.org/0000-0002-0697-8996","observed_orcids":["https://orcid.org/0000-0002-0697-8996"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Glynn","raw_affiliation_strings":["Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","Submitted April 6, 2018","Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","accepted November 12, 2018"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Submitted April 6, 2018","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","institution_ids":[]},{"raw_affiliation_string":"accepted November 12, 2018","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004416630","display_name":"Sebastian Schneewei\u00df","orcid":"https://orcid.org/0000-0003-2575-467X","observed_orcids":["https://orcid.org/0000-0003-2575-467X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sebastian Schneeweiss","raw_affiliation_strings":["Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","Submitted April 6, 2018","Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","accepted November 12, 2018"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Submitted April 6, 2018","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","institution_ids":[]},{"raw_affiliation_string":"accepted November 12, 2018","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059157113","display_name":"Joshua J. Gagne","orcid":"https://orcid.org/0000-0001-5428-9733","observed_orcids":["https://orcid.org/0000-0001-5428-9733"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua J. Gagne","raw_affiliation_strings":["Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","Submitted April 6, 2018","Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","accepted November 12, 2018"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Submitted April 6, 2018","institution_ids":[]},{"raw_affiliation_string":"Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com)","institution_ids":[]},{"raw_affiliation_string":"accepted November 12, 2018","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5083832003"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":null,"apc_paid":null,"fwci":1.2449,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.82831203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"30","issue":"2","first_page":"204","last_page":"211"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14374","display_name":"Statistical Methods in Epidemiology","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14374","display_name":"Statistical Methods in Epidemiology","score":0.4487000107765198,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.1348000019788742,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","score":0.11469999700784683,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9070000052452087},{"id":"https://openalex.org/keywords/case-crossover-design","display_name":"case-crossover design","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8569999933242798},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9549999833106995},{"id":"https://openalex.org/keywords/clarithromycin","display_name":"clarithromycin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/erythromycin","display_name":"erythromycin","score":0.9739999771118164},{"id":"https://openalex.org/keywords/rhabdomyolysis","display_name":"rhabdomyolysis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ischemic-events","display_name":"ischemic events","score":0.8830000162124634},{"id":"https://openalex.org/keywords/saturated-models","display_name":"saturated models","score":0.6119999885559082},{"id":"https://openalex.org/keywords/active-comparator","display_name":"active comparator","score":0.5920000076293945},{"id":"https://openalex.org/keywords/effect-heterogeneity","display_name":"heterogeneous effects","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.7171374559402466},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.6715887784957886},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.630872368812561},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6220383644104004},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6167392730712891},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.555741548538208},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.5372742414474487},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5201383233070374},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.503471314907074},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.420871764421463},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3580520749092102},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.32334715127944946},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.2194060981273651},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.12994349002838135},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.1271989643573761},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1092701256275177},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067575","descriptor_name":"Administrative Claims, Healthcare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068760","descriptor_name":"Serotonin and Noradrenaline Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068760","descriptor_name":"Serotonin and Noradrenaline Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077144","descriptor_name":"Clopidogrel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077626","descriptor_name":"Implementation Science","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012206","descriptor_name":"Rhabdomyolysis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D012206","descriptor_name":"Rhabdomyolysis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017291","descriptor_name":"Clarithromycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017291","descriptor_name":"Clarithromycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017963","descriptor_name":"Azithromycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017963","descriptor_name":"Azithromycin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057286","descriptor_name":"Electronic Health Records","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/ede.0000000000000944","doi":"https://doi.org/10.1097/ede.0000000000000944","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ede.0000000000000944","pdf_url":null,"source":{"id":"https://openalex.org/S15470582","display_name":"Epidemiology","issn_l":"1044-3983","issn":["1044-3983","1531-5487"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epidemiology","raw_type":"journal-article"},{"id":"pmid:30433922","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30433922","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epidemiology (Cambridge, Mass.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1553345686","https://openalex.org/W1561057973","https://openalex.org/W1762915406","https://openalex.org/W1977946411","https://openalex.org/W1978544117","https://openalex.org/W1988050416","https://openalex.org/W1988733658","https://openalex.org/W2001688139","https://openalex.org/W2035380893","https://openalex.org/W2036080446","https://openalex.org/W2053379248","https://openalex.org/W2055162590","https://openalex.org/W2061136308","https://openalex.org/W2062834232","https://openalex.org/W2096206421","https://openalex.org/W2102393690","https://openalex.org/W2102425178","https://openalex.org/W2109587213","https://openalex.org/W2118534378","https://openalex.org/W2128043538","https://openalex.org/W2130547542","https://openalex.org/W2136527705","https://openalex.org/W2144418705","https://openalex.org/W2164561317","https://openalex.org/W2322013678","https://openalex.org/W2332669751","https://openalex.org/W2471354286","https://openalex.org/W2549271178","https://openalex.org/W2625393045","https://openalex.org/W2792265963","https://openalex.org/W6720389584"],"related_works":["https://openalex.org/W4416290680","https://openalex.org/W2911571269","https://openalex.org/W3130263884","https://openalex.org/W4296777581","https://openalex.org/W3110026634","https://openalex.org/W2273965931","https://openalex.org/W2145756429","https://openalex.org/W2967522948","https://openalex.org/W2181753001","https://openalex.org/W2017501956"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,184,208],"case-crossover":[2,71],"design":[3,23],"may":[4,243],"be":[5,244],"useful":[6,222],"for":[7,223],"evaluating":[8],"the":[9,22,92,104,107,117,145,203,218,247],"clinical":[10],"impact":[11],"of":[12,40,46,91,153,189,239,249],"drug-drug":[13,214],"interactions":[14],"in":[15,24,168,246],"electronic":[16],"healthcare":[17,32],"data;":[18],"however,":[19],"experience":[20],"with":[21,43,73,78,97,113,116,197],"this":[25,148],"context":[26],"is":[27,221],"limited.":[28],"METHODS:":[29],"Using":[30],"US":[31],"claims":[33],"data":[34],"(1994-2013),":[35],"we":[36],"evaluated":[37],"two":[38,93],"examples":[39],"interacting":[41],"drugs":[42],"prior":[44,114,169],"evidence":[45,115],"harm:":[47],"(1)":[48,74],"cytochrome":[49],"P450":[50],"(CYP)3A4-metabolized":[51],"statins":[52],"+":[53,62],"clarithromycin":[54],"or":[55,64,98,228,237],"erythromycin":[56],"and":[57,59,66,82,95,134,193],"rhabdomyolysis;":[58],"(2)":[60,96],"clopidogrel":[61,146,199],"fluoxetine":[63],"fluvoxamine":[65],"ischemic":[67],"events.":[68],"We":[69],"conducted":[70],"analyses":[72],"a":[75,79,83,212],"three-parameter":[76,108,209],"model":[77,86,109,149,186,210,220],"product":[80],"term":[81,121],"six-parameter":[84],"saturated":[85,185,219],"that":[87],"distinguished":[88],"initiation":[89],"order":[90],"drugs;":[94],"without":[99,135],"active":[100,118,172,241],"comparators.":[101],"RESULTS:":[102],"In":[103,144],"statin":[105],"example,":[106,147],"produced":[110,150,202],"estimates":[111,190],"consistent":[112],"comparator":[119,173,242],"(product":[120],"odds":[122],"ratio":[123],"[OR]":[124],"=":[125,131,137,141,156,159,177,181],"2.05,":[126],"95%":[127,139,158,179],"confidence":[128],"interval":[129],"[CI]":[130],"1.00,":[132],"4.23)":[133],"(OR":[136,155,176],"1.99,":[138],"CI":[140,180],"1.04,":[142],"3.81).":[143],"results":[151],"opposite":[152],"expectation":[154],"0.78,":[157],"0.68,":[160],"0.89),":[161],"but":[162],"closer":[163],"to":[164,234],"what":[165],"was":[166,174],"observed":[167],"studies":[170],"when":[171],"used":[175],"1.03,":[178],"0.90,":[182],"1.19).":[183],"revealed":[187],"heterogeneity":[188,227],"across":[191,231],"strata":[192,196,236],"considerable":[194],"confounding;":[195],"concordant":[198],"exposure":[200],"likely":[201],"least":[204],"biased":[205],"estimates.":[206],"CONCLUSION:":[207],"assumes":[211],"common":[213],"interaction":[215],"effect,":[216],"whereas":[217],"identifying":[224],"potential":[225],"effect":[226],"differential":[229],"confounding":[230],"strata.":[232],"Restriction":[233],"certain":[235],"use":[238],"an":[240],"necessary":[245],"presence":[248],"within-person":[250],"confounding.":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-29T00:00:00"}